Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients

Fig. 3

T1-weighted gadolinium-enhanced brain MRI of a 64-year-old man. Olioprogression lesions were noted in left occipital lobe (A), right basal ganglia (B), and left cerebellum (C). The patient continued afatinib after surgically removing the left occipital tumor with adjuvant WBRT. After a 6-month follow-up, the tumor was controlled in the left occipital (D) but progressed in the right basal ganglia (E) and left cerebellum (F)

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us